22nd Century Group, Inc. (XXII) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. 22nd Century Group, Inc. is an agricultural biotechnology company focused on tobacco harm reduction, offering proprietary reduced nicotine content (RNC) tobacco products and providing contract manufacturing services for conventional combustible tobacco products. The company is a smaller reporting company and a non-accelerated filer.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | YTD 2024 (6 Months) | Q2 2023 (3 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Net Revenues | $7,947 | $14,416 | $8,050 | $16,977 |
| Gross Profit (Loss) | $570 | $(559) | $(961) | $(944) |
| Operating Loss | $(2,047) | $(6,481) | $(12,043) | $(22,446) |
| Net Loss (Continuing Ops) | $(2,214) | $(7,664) | $(13,708) | $(24,537) |
| Net Loss (Total) | $(1,112) | $(6,851) | $(20,539) | $(38,721) |
| Cash and Equivalents | $1,279 (as of June 30, 2024) | |||
| Total Debt (Carrying Value) | $7,546 (as of June 30, 2024) | |||
| Working Capital Deficit | $(2,249) (Continuing Ops) |
Note: All amounts in thousands, except per share data. Discontinued operations (hemp/cannabis) generated a net income of $1,102 for Q2 2024 and $813 for YTD 2024.
Material Changes vs. Prior Period
- Revenue Decline: Net revenues decreased 1.3% in Q2 2024 compared to Q2 2023, driven by a 19.8% drop in filtered cigar volumes as the company transitions to higher-margin cigarette manufacturing. Cigarette revenue increased 8.2% due to price hikes and seasonal demand.
- Expense Reduction: Operating expenses plummeted 76.4% year-over-year in Q2 2024 ($2,617 vs. $11,082). SG&A expenses dropped 77.0% due to headcount reductions and lower consulting costs. R&D expenses fell 68.7%.
- Profitability Improvement: The company achieved a gross profit of $570 in Q2 2024, reversing a gross loss of $961 in the prior year period. Operating loss narrowed significantly to $2,047 from $12,043.
- Debt Restructuring: The company extinguished its Subordinated Note to Omnia in April 2024 via a debt-for-equity swap. Additionally, $2,328 of the Senior Secured Credit Facility was converted to equity in May 2024.
- Capital Structure: A 1-for-16 reverse stock split was effected in April 2024. The company raised approximately $3.9 million in net proceeds via a Registered Direct Offering in April 2024.
Guidance, Outlook, Risks, and Contingencies
- Going Concern: Management has expressed substantial doubt about the company's ability to continue as a going concern for one year following the report date due to significant accumulated deficits ($385.6 million) and negative cash flows from operations ($6.97 million YTD). The company is evaluating expense reduction and financing strategies.
- Nasdaq Compliance: The company received a deficiency letter regarding the minimum bid price requirement (stock trading below $1.00). It has until January 13, 2025, to regain compliance or face delisting. It also has an extension until October 1, 2024, to meet stockholders' equity requirements.
- Litigation:
- Insurance Dispute: Ongoing litigation against Dorchester Insurance regarding a business interruption claim of approximately $9 million following a 2022 fire at the Grass Valley facility.
- KeyGene Dispute: Arbitration initiated by KeyGene seeking $1.885 million for terminated research agreements.
- Settlements: A $3 million class action settlement (covered by insurance) is expected to be disbursed in Q3 2024. A $768,000 shareholder derivative settlement is expected in Q4 2024.
- Debt Covenants: The Senior Secured Credit Facility includes revenue targets and requires the maintenance of restricted cash. The company has received waivers for certain revenue targets but remains subject to financial covenants.
Investor Verification Checklist
- Liquidity Runway: Verify the sufficiency of the $1.279 million cash balance against projected operating burn rates and debt service obligations.
- Debt Conversion Terms: Review the specific terms of the Senior Secured Credit Facility conversions and the impact of the $1.69 warrant exercise price on future dilution.
- Insurance Recovery: Monitor the status of the $9 million business interruption claim against Dorchester Insurance, which is critical to asset recovery.
- Nasdaq Status: Track the stock price to ensure it meets the $1.00 minimum bid price requirement to avoid delisting.
- Discontinued Operations: Confirm the final disposition of the hemp/cannabis assets and liabilities held for sale.